(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2012
thousands of euros
2011
2012
Variation at current exchange rates
Variation at constant exchange rates
France
292,181
325,900
+11.5%
+11.5%
International :
231,034
240,394
+4.1%
+2.4%
Incl. Europe excluding France
185,014
184,489
-0.3%
-0.8%
Incl. North America
38,416
45,345
+18.0%
+9.6%
Incl. Other countries
7,604
10,560
+38.9%
+41.0%
Group Total
523,215
566,294
+8.2%
+7.5%
thousands of euros
2011
2012
Variation at current exchange rates
Variation at constant exchange rates
Non-proprietary Homeopathic Medicines
265,636
292,025
+9.9%
+9.6%
OTC Specialties
257,748
273,776
+6.2%
+5.1%
Other
-0,169
0,493
Group Total
523,215
566,294
+8.2%
+7.5%
QUARTERLY ACTIVITY IN 2012 (variation at current rate)
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
France
70,466
74,188
+5.3%
59,744
71,210
+19.2%
79,943
88,028
+10.1%
82,028
92,474
+12.7%
International :
58,478
54,904
-6.1%
37,128
41,216
+11.0%
67,885
69,839
+2.9%
67,543
74,435
+10.2%
Incl. Europe excluding France
47,024
41,807
-11.1%
28,880
28,889
+0.0%
55,013
55,345
+0.6%
54,097
58,448
+8.0%
Incl. North America
9,566
10,285
+7.5%
6,113
9,861
+61.3%
11,077
11,136
+0.5%
11,660
14,063
+20.6%
Incl. Other countries
1,888
2,812
+48.9%
2,135
2,466
+15.5%
1,795
3,358
+87.1%
1,786
1,924
+7.7%
Group Total
128,944
129,092
+0.1%
96,872
112,426
+16.1%
147,828
157,867
+6.8%
149,571
166,909
+11.6%
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter
thousands of euros
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
2011
2012
Var.
Non-proprietary Homeopathic
Medicines
69,371
73,427
+5.8%
62,414
70,206
+12.5%
63,246
69,959
+10.6%
70,605
78,433
+11.1%
OTC Specialties
59,417
55,576
-6.5%
34,499
42,007
+21.8%
84,645
87,811
+3.7%
79,187
88,382
+11.6%
Other
0,156
0,089
-0,041
0,213
-0,063
0,097
-0,221
0,094
Group Total
128,944
129,092
+0.1%
96,872
112,426
+16.1%
147,828
157,867
+6.8%
149,571
166,909
+11.6%
FOURTH QUARTER HIGHLIGHTS
Sales revenue in the fourth quarter of 2012 grew by 11.6% (10.6% at constant exchange rates):
In France, sales of non-proprietary medicines increased by 16.3% due to price increases applied to some of them.
OTC specialties increased, especially in France, Poland, Russia and the US, particularly through the winter OTC specialties.
In the United States, the settlement agreement signed on March 6, 2012 which shall put an end to all current class action proceedings (with the exception of the claim relating to Children's Coldcalm®) obtained final approval of the San Diego Court in its judgment dated October 31, 2012. Appeals were filed against this judgment which admissibility is under consideration by the Court of Appeal.
On December 17, 2012, the company “Pierre Fabre SA” sold its shareholding in BOIRON (3,330,436 shares) to the benefit of some members of the BOIRON family group for 1,289,593 shares and of the company BOIRON itself for 2,040,843 shares within the frame of the applicable share buyback program. The shares acquired by the company BOIRON were cancelled on January 1, 2013 in accordance with the Board of Directors' decision dated December 19, 2012.
At December 31, 2012, the group's net cash position exceeded 90 million euros.
Operating income in 2012 is expected to increase significantly as compared to 2011.
Our next update: March 13, 2013, after the close of the stock market, publication of 2012 results.
Financial information manager: Philippe MONTANT
Contact for financial information: Véronique BOUSCAYROL
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at : www.boiron.com
Information réglementée
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-30762-cp-boiron-240113.pdf
Communiqués au titre de l'obligation d'information permanente :
- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-30762-cp-boiron-240113.pdf
<!-- 90 -->
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free